Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. It operates through the Hyper-immune Products and Research and Development (R&D) segments. The Hyper-immune Products segment includes income and expenses directly attributable to Travelan and Protectyn activities. The Research and Development segment refers to the group’s R&D projects performed in Australia and United States. The company was founded on January 13, 1994, and is headquartered in Blackburn, Australia.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Immuron Limited - ADR market cap is $7.26M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Immuron Limited - ADR 52 week high is $1.99 as of November 21, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Immuron Limited - ADR 52 week low is $0.6765 as of November 21, 2026.
Immuron Limited - ADR stock price today is $0.8998.
Immuron Limited - ADR stock price yesterday was $0.85.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Immuron Limited - ADR's P/E ratio is -2.67.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Immuron Limited - ADR P/B ratio is 0.9389.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Immuron Limited - ADR 50-day moving average is $1.02.